Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L G Feun

Showing results (41-50 of 85) with videos related to

Pageof 9
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1986
Clinical pharmacology of 4-demethoxydaunorubicin (DMDR)K Lu, N Savaraj, J Kavanagh, et al.
Journal of Neuro-Oncology|January 1, 1985
Phase I clinical trial of intralesional or intraventricular leukocyte interferon for intracranial malignanciesE A Obbens, L G Feun, M E Leavens, et al.
Journal of Neuro-Oncology|January 1, 1987
Central nervous system (CNS) penetration of homoharringtonine (HHT)N Savaraj, L G Feun, K Lu, et al.
Cancer Drug Delivery|January 1, 1986
Phase II trial of intracarotid BCNU and cisplatin in primary malignant brain tumorsL G Feun, Y Y Lee, W K Yung, et al.
American Journal of Clinical Oncology|December 1, 1995
Phase II trial of piritrexim and DTIC using an alternating dose schedule in metastatic melanomaL G Feun, W A Robinson, N Savaraj, et al.
Cancer Detection and Prevention|January 11, 1992
Descriptive analysis of the tumor registry experience for malignant melanoma from 1977 to 1986 at the University of Miami School of Medicine/Jackson Memorial HospitalW A Raub, L G Feun, R C Duncan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1991
Phase II trial of piritrexim in metastatic melanoma using intermittent, low-dose administrationL G Feun, R Gonzalez, N Savaraj, et al.
Cancer|August 15, 1988
Chemotherapy for metastatic Merkel cell carcinoma. Review of the M.D. Anderson Hospital's experienceL G Feun, N Savaraj, S S Legha, et al.
Gynecologic Oncology|January 15, 1999
A phase II study of intraperitoneal cisplatin and thiotepa in residual ovarian carcinoma: a Gynecologic Oncology Group studyL G Feun, J A Blessing, F J Major, et al.
Cell & Developmental Biology|August 19, 2017
Relationship of Metabolic Alterations and PD-L1 Expression in Cisplatin Resistant Lung CancerM Wangpaichitr, H Kandemir, Y Y Li, et al.
Pageof 9

Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
Cancer Chemotherapy and Pharmacology|January 1, 1986
Clinical pharmacology of 4-demethoxydaunorubicin (DMDR)K Lu, N Savaraj, J Kavanagh, et al.
Journal of Neuro-Oncology|January 1, 1985
Phase I clinical trial of intralesional or intraventricular leukocyte interferon for intracranial malignanciesE A Obbens, L G Feun, M E Leavens, et al.
Journal of Neuro-Oncology|January 1, 1987
Central nervous system (CNS) penetration of homoharringtonine (HHT)N Savaraj, L G Feun, K Lu, et al.
Cancer Drug Delivery|January 1, 1986
Phase II trial of intracarotid BCNU and cisplatin in primary malignant brain tumorsL G Feun, Y Y Lee, W K Yung, et al.
American Journal of Clinical Oncology|December 1, 1995
Phase II trial of piritrexim and DTIC using an alternating dose schedule in metastatic melanomaL G Feun, W A Robinson, N Savaraj, et al.
Cancer Detection and Prevention|January 11, 1992
Descriptive analysis of the tumor registry experience for malignant melanoma from 1977 to 1986 at the University of Miami School of Medicine/Jackson Memorial HospitalW A Raub, L G Feun, R C Duncan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1991
Phase II trial of piritrexim in metastatic melanoma using intermittent, low-dose administrationL G Feun, R Gonzalez, N Savaraj, et al.
Cancer|August 15, 1988
Chemotherapy for metastatic Merkel cell carcinoma. Review of the M.D. Anderson Hospital's experienceL G Feun, N Savaraj, S S Legha, et al.
Gynecologic Oncology|January 15, 1999
A phase II study of intraperitoneal cisplatin and thiotepa in residual ovarian carcinoma: a Gynecologic Oncology Group studyL G Feun, J A Blessing, F J Major, et al.
Cell & Developmental Biology|August 19, 2017
Relationship of Metabolic Alterations and PD-L1 Expression in Cisplatin Resistant Lung CancerM Wangpaichitr, H Kandemir, Y Y Li, et al.
Pageof 9